NCT04946721View on ClinicalTrials.gov

2177GCCC:ID'Ing tx Targets and Biomarkers for Ocular Surface Disease in Pt w/ oGVHD

RecruitingOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

April 27, 2022

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Dry Eye DiseaseoGVHD
Interventions
DIAGNOSTIC_TEST

The standard care exam and biological specimens' collection

During each visit, in addition to standard of care exams, certain biological specimens ( ocular surface wash, mucocellular material, corneal filaments or impression cytology of conjunctiva, blood or serum) will be collected.

Trial Locations (1)

21201

RECRUITING

Geenebaum Cancer Center, University of Maryland Medical Center, Baltimore

All Listed Sponsors
lead

University of Maryland, Baltimore

OTHER